ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGL Angle Plc

14.00
-0.25 (-1.75%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.75% 14.00 13.50 14.50 14.25 13.75 14.25 1,857,444 16:27:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 1.04M -21.69M -0.0832 -1.68 36.48M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 14.25p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £36.48 million. Angle has a price to earnings ratio (PE ratio) of -1.68.

Angle Share Discussion Threads

Showing 31551 to 31573 of 33850 messages
Chat Pages: Latest  1270  1269  1268  1267  1266  1265  1264  1263  1262  1261  1260  1259  Older
DateSubjectAuthorDiscuss
12/2/2024
08:33
Nothing wrong with 'a raise'. It all depends on the price.

Morning Anglers. This ship is watertight. No leaks okay.

boris cobaka
12/2/2024
08:04
I suspect they wasted a lot of time immediately post FDA although they're getting up to speed now...but they must be very concerned about being taken out on the cheap cheap...
sawney
12/2/2024
07:38
I thought the same re a high risk company, although in fairness that’s correct.

I totally agree it would be good know where the forecast £6m is coming from and likewise the numbers that sit behind the forecast to be break even by end of 2025. Personally I think a raise is pretty much guaranteed but it need not he seen as the end of world. There’s still so far to go in terms of commercialisation so IF they
can get to break even within <2 years it’s pretty decent.

adw198
12/2/2024
07:22
I wasn't totally convinced the "we are a high risk company" and we are trying to do this "on a shoe string" would have been that encouraging to new potential invetors.

Also, I don't see how they have got away with the further delays to Ovarian and Prostate without more comment/ challenge.

Well perhaps I do. They came up with yet another amazing use of Parsortix that may be years off coming to anything and many investors seem to have happily accepted that in lieu of the LDTs anytime soon.

It would be helpful to know how much of the FY24 target revenue is contracted and planned, not planned, blue sky?

Going beyond that they now seem to be dangling the carrot that no further raises will may be needed. But they are very light on how in reality they will avoid that. Just seems to be that "something will turn up"

bagpuss67
09/2/2024
18:33
Borrowed from elsewhere :



Perhaps somewhat redundant after timbos excellent post presentation report but a reminder nonetheless of the sterling work currently being undertaken to progress all aspects of Parsortix.

All eyes now on the Liquid Biopsy Conference at the end of the month.

gooosed
09/2/2024
16:42
Half right!
gspanner
09/2/2024
16:12
Buyers moving in
rb1947
09/2/2024
15:36
Looks like we were wrong again 😂
gspanner
09/2/2024
12:55
Might be some more buying this afternoon from across the pond after the presentation yesterday? I am a holder, so pleased to see some new interest emerging here. It is a very much undervalued prospect as indicated by others
spa362
09/2/2024
12:48
Only really believable if accompanied by double this volume mind you….
gspanner
09/2/2024
12:28
Well perhaps some of the ‘high net worth’ folk in the US who saw the presentation yesterday agree with me that this remains criminally undervalued!
gspanner
09/2/2024
12:10
AN said that getting the message out to both scientists and investors is key to moving the share price forward.
As well as closing deals of course.
The Annual San Diego conference is one of the most important ones,so a deal to coincide would be helpful as well as getting to more influencers during the coffee breaks!

fhmktg
09/2/2024
12:02
Tight lines indeed....

If there's the merest whiff of a deal this may build some momentum. Not saying there is. It might just be my lunch. Egg and anchovy roll with a side of durian salad.

boris cobaka
09/2/2024
11:12
Morning Anglers!

A wee nibble.

Showing as a sell.

boris cobaka
09/2/2024
10:24
Angle attending 8th Annual Liquid Biopsy for Precision Oncology Summit as a Program Partner

February 28 - March 1 2024
San Diego, CA

gooosed
08/2/2024
20:17
Thanks for the conference call link



Really interesting. Very innovative and potentially high yield. Sounds like there is a lot to come over the next while. I do think the upside on this share is massive compared with the downside. I do actually doubt that there will be opportunities to buy much lower than this now.

spa362
08/2/2024
19:21
Another day another sucker as they say!
bones699
08/2/2024
18:15
Thanks Miavoce & Goosed.
radderssandy
08/2/2024
17:27
Video of the Angle conference presentation which took place today (thanks for flagging the conference goosed).
miavoce
08/2/2024
16:19
New lower low since the 'spike'.
Not much volume but enough to let it drip lower. "Alamo' stops to be hit soon.

boris cobaka
08/2/2024
15:12
Looks like a drifting down back to 10p area
jibba jabber
08/2/2024
09:19
She is a just a bitter ex employee I am sure you must have been a joy to work with NOT
rb1947
08/2/2024
09:05
Aren’t ET claims in the public domain? If so could someone direct me to the case so I can read what bones699 is so bitter about?
adw198
Chat Pages: Latest  1270  1269  1268  1267  1266  1265  1264  1263  1262  1261  1260  1259  Older

Your Recent History

Delayed Upgrade Clock